US Nuclear Corp Reports 54% Reduction in Net Loss, Projects Profitability with Growing Backlog
Summary
Full Article
US Nuclear Corp (OTC: UCLE) reported a substantial 54% reduction in net loss for the second quarter while projecting profitability for the third quarter, supported by an increased backlog extending into 2026. The company's financial performance shows marked improvement when adjusting for non-cash charges and timing issues affecting quarterly results.
CEO Bob Goldstein explained that excluding a $451,459 non-cash charge for incentive out-of-the-money warrants for consultants and employees in the first quarter, along with an order shipped immediately after the quarter ended, the company would have shown a net loss of less than $301,000 for the first half of 2025. This represents a 49% reduction compared to the $617,404 loss recorded during the first half of 2024. The second quarter results approached breakeven, and the company anticipates achieving profitability in the third quarter and for the full year.
The company has implemented a new policy of declining low-margin contracts or those carrying loss risks, contributing to improved financial performance. Goldstein stated, "We will continue to employ our new policy of turning down jobs with low margins, or with risk of losses," indicating a strategic shift toward more profitable business operations.
Following the second quarter, US Nuclear completed two significant transactions totaling $475,000 with equity partners in the nuclear fusion sector. The company held 622,710 shares in MIFTI, an early-stage company developing thermonuclear fusion-powered reactors, and 2 million shares in MIFTEC, a sister company focused on radio-isotopes. The two entities merged on September 10, 2025, resulting in MIFTEC shareholders receiving 0.2 shares of MIFTI for each MIFTEC share owned. This consolidation left US Nuclear with 1,022,710 MIFTI shares, representing substantial potential upside in the emerging nuclear fusion market.
Goldstein expressed enthusiasm about the merger, noting, "We are excited about this transaction, will continue to work with them to help optimize the long-term value of our investment, and we look for further opportunities in the fission and fusion reactor space." The company's strategic positioning in nuclear fusion technology represents significant long-term growth potential as global interest in clean energy solutions accelerates.
Operational expansion continues as the company seeks to strengthen its sales infrastructure. Nikki Truax, Director of Operations of Overhoff Technology, the company's primary manufacturing and sales operation, announced active recruitment efforts for sales representatives, distributors, and an experienced Vice President of Sales. The company is integrating extensive product lines from Optron, now consolidated with Overhoff Technologies in Milford, Ohio, along with ECC, the calibration and service division.
Truax emphasized the scale of operations, stating, "Our combined product lines total over 250 distinct products, and we need to dramatically expand the number of skilled technical salespeople, to continue to provide the best possible service that our customers have become accustomed to." This expansion reflects growing market demand and the company's commitment to maintaining high service standards across its diversified product portfolio.
The company's improved financial trajectory and strategic investments in nuclear fusion technology position it advantageously within the evolving energy sector. The projected profitability and growing backlog through 2026 suggest sustainable growth potential as global energy markets increasingly prioritize nuclear and fusion technologies for clean energy solutions. Financial details for the second quarter are available through the company's regulatory filings at https://www.sec.gov/edgar/searchedgar/companysearch.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at NewMediaWire
Article Control ID: 268417